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Cystathionine β-synthaseHydrogen sulﬁde (H2S) produced by cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) in the
transsulfuration pathway of homocysteine plays a number of pathophysiological roles. Hyperhomocysteinemia
is involved in kidney ﬁbrosis. However, the role of H2S in kidney ﬁbrosis remains to be deﬁned. Here, we inves-
tigated the role of H2S and its acting mechanism in unilateral ureteral obstruction (UO)-induced kidney ﬁbrosis
in mice. UO decreased expressions of CBS and CSE in the kidney with decrease of H2S concentration. Treatment
with sodium hydrogen sulﬁde (NaHS, a H2S producer) during UO reduced UO-induced oxidative stress with
preservations of catalase, copper-zinc superoxide dismutase (CuZnSOD), and manganese superoxide dismutase
(MnSOD) expression, and glutathione level. In addition, NaHS mitigated decreases of CBS and CSE expressions,
and H2S concentration in the kidney. NaHS treatment attenuated UO-induced increases in levels of TGF-β1, ac-
tivated Smad3, and activatedNF-κB. This study provided theﬁrst evidence of involvement of the transsulfuration
pathway and H2S in UO-induced kidney ﬁbrosis, suggesting that H2S and its transsulfuration pathway may be a
potential target for development of therapeutics for ﬁbrosis-related diseases.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
For decades, hydrogen sulﬁde (H2S) has been known as a toxic gas,
and, together with nitric oxide (NO) and carbon monoxide (CO), it is
currently recognized as an endogenous gaseous physiological molecule
[1–3]. H2S is synthesized from cysteine by two pyridoxal-5′-phosphate-
dependent enzymes, cystathionine β-synthase (CBS) and cystathionine
γ-lyase (CSE), and a pyridoxal-5′-phosphate-independent enzyme,
3-mercaptpyruvate sulfurtransferase (3-MST), in most mammalian
tissues, including the kidney [4–7].
Progression of ﬁbrosis is associated with oxidative stress, inﬂam-
matory responses, vascular tone, and intracellular signaling pathways
[8,9]. Recent studies in human and animal have demonstratedCBS, cystathionine β-synthase;
, 5,5-dithiobis (2-nitrobenzoic
tion rate; GSSG, oxidized gluta-
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chool of Medicine, Kyungpook
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rights reserved.involvement of H2S in those factors in various diseases, including ath-
erosclerosis, ischemia and reperfusion (I/R) injury, hypertension, and
end-stage renal disease (ESRD) [5,6]. It has been reported that pro-
gression of kidney ﬁbrosis is associated with abnormal metabolism
of homocysteine, a precursor of H2S [10–14]. However, the role of
H2S and its producing transsulfuration pathway in kidney ﬁbrosis re-
mains to be deﬁned. In the present study we investigated the role of
H2S and its producing transsulfuration pathway in kidney ﬁbrosis
using the unilateral ureteral obstruction animal model which is a
well-established in vivo experimental model for kidney ﬁbrosis [8].
Here, we report for the ﬁrst time on the association of ureteral ob-
struction (UO)-induced kidney ﬁbrosis with decreases of H2S levels
and expression of its regulating enzymes; in addition, treatment
with H2S donor resulted in inhibition of UO-induced kidney ﬁbrosis.
These ﬁndings suggest that H2S and its transsulfuration pathway
may be an important target for development of therapeutics for treat-
ment of ﬁbrosis-related diseases.
2. Materials and methods
2.1. Animal preparation
Age-matched (8 weeks) C57BL/6 male mice (Koatech, Gyounggido,
Korea) were used in performance of experiments. All studies were
conducted in accordance with guidelines provided by the Animal Care
and Use Committee of Kyungpook National University. As previously
1990 K.-J. Jung et al. / Biochimica et Biophysica Acta 1832 (2013) 1989–1997described [15], for induction of unilateral ureteral obstruction, the left
kidney was exposed through a ﬂank incision and the ureter was tied
completely using 6/0 nylon under anesthetization with pentobarbital
sodium (50 mg/kg BW). The same procedure, except for tying of the
ureter, was used for performance of the sham operation. Somemice re-
ceived daily intraperitoneal administration of sodium hydrosulﬁde hy-
drate (NaHS; 1.12, 5.6, or 28 μg/kg BW, Sigma, St. Louis, MO), a H2S
donor, or 0.9%NaCl (vehicle), beginning ondayone after UO for a period
of 6 days. In water, NaHS dissociates instantly to yield HS− and H+ and
then ~20% are recombined to form H2S [16–20]. This treatment did not
induce any signiﬁcant side effects such as decrease of food intake
and abnormal behavior. NaHSwas prepared freshly before use. Each ex-
perimental animal group included more than four mice. To use for bio-
chemical and histological study, kidneys were frozen in liquid nitrogen
immediately after extract or perfusion-ﬁxed, respectively.2.2. Histology
As previously described [21], to evaluate collagen deposition, kidneys
were perfusion-ﬁxed with PLP (4% paraformaldehyde, 75 mM L-lysine,
10 mM sodium periodate; Sigma, St. Louis, MO). Kidney parafﬁn-
sections were stained with Masson trichrome according to a standard
protocol. Brieﬂy, 4 μm-thick parafﬁn kidney sections were incubated
in Bouin's solution (Sigma, St. Louis, MO) overnight at room tem-
perature, and stained sequentially with Weigert's hematoxylin for
10 min, Biebrich scarlet-acid fuchsin for 5 min, phosphotungstic-
phosphomolybdic acid (Sigma, St. Louis, MO) for 5 min, and aniline
blue (Sigma-Aldrich) for 10 min. The section was incubated in 1% acetic
acid for 2 min, dehydrated through a graded series of ethanol solutions
to xylene, and then mounted with Permount (Fisher Scientiﬁc,
Pittsburgh, PA). Pictures were taken in the cortex and collagen deposi-
tion was quantiﬁed using the i-solution DT image acquisition and analy-
sis program (IMT i-solution, Vancouver, Canada) incorporating a Nikon
Fx35 (Nikon, Japan).2.3. Blood pressure
Blood pressure (BP) in the conscious animal was measured by a
non-invasive tail-cuffmethod (CODA 2, Kent Scientiﬁc Corp., Torrington,
CT) [22,23]. For accurate evaluation of BP, mice were acclimated for
1 week before the experiment.2.4. Tissue H2S-producing capacity
Tissue H2S-producing capacity wasmeasured using spectrophotom-
etry as described previously with slight modiﬁcations [10,24,25]. Brief-
ly, tissueswere homogenized in ice-cold 100 mMpotassiumphosphate
buffer (pH 7.4)with protease inhibitors. Onehundredmicroliters of ho-
mogenate was mixed with 100 μl of 1% zinc acetate, 100 μl of borate
buffer (pH 10.0), 200 μl of 20 mM N,N-dimethyl-p-phenylenediamine
dihydrochloride in 7.2 M HCl, and 200 μl of 30 mM FeCl3 in 1.2 M HCl,
followed by incubation for 15 min at 37 °C. The samplewas centrifuged
for 5 min at 10,000 rpm at 4 °C. The supernatant was removed and
optical density was measured at 670 nm. To calculate actual O.D. of
samples, O.D. of each sample at zero time was deducted from the O.D.
of each sample. The standard curve of NaHS solution was used for
calculation of H2S concentration. Although we have adapted methods
which have been used for many studies [10,24,25], there has been con-
troversy in sulﬁde quantiﬁcation techniques; because strong acid in
the assay could release great amount of free acid-labile sulﬁde from
samples and H2S is unstable in air, the H2S valuemay include an artifact
of the technique and is acid-labile form of H2S rather than free H2S
[5,17].2.5. Measurement of superoxide formation in the kidney
Aspreviously described [22],wedetermined superoxide levels in kid-
ney homogenates using dihydroethidium (DHE; Sigma, St. Louis, MO).
Brieﬂy, 20 μl of protein lysate was placed in 96-well plates; 200 μl of
10 μM DHE was added to 96-well plates containing 20 μl of kidney
lysates. For measurement of intensity, a ﬂuorescence spectrometer was
read for 10 min at excitation/emissionﬁlters of 544 nm/612 nm. Control
was determined by DHE alone. Data represent relative ﬂuorescence
intensity.
2.6. Measurement of hydrogen peroxide in the kidney
A ferric sensitive dye, xylenol orange (Sigma, St. Louis, MO), was
used for determination of hydrogen peroxide (H2O2) levels in tissue
samples. H2O2 oxidizes iron (II) to iron (III) in the presence of sorbi-
tol, which functions as a catalyst. Iron (III) forms a purple complex
with xylenol orange, as previously described [26].
2.7. Measurement of lipid peroxidation in the kidney
Thiobarbituric acid-reactive substances (TBARS, Sigma, St. Louis,
MO) were determined as a measure of lipid peroxidation. Samples
were evaluated for malondialdehyde (MDA) production via a spec-
trophotometric assay for TBARS [27]. The extinction coefﬁcient at
532 nm of 153 000 M−1 cm−1 for the chromophore was used to cal-
culate the MDA-like TBARS produced.
2.8. Measurement of ratio of oxidized glutathione (GSSG) to total
glutathione in the kidney
The ratio of oxidized glutathione (GSSG) to total glutathione
(reduced glutathione + GSSG) was measured using an enzymatic
recycling method, as previously described [28,29] with slight modiﬁ-
cation. Because GSH and related thiols are sensitive to oxidation and
degradation during sampling and analysis, to minimize those artifact
samples were quickly harvested at liquid nitrogen, stored at −70 °C
until use and quickly analyzed. The amount of total glutathione was
determined by formation of 5-thio-2-nitrobenzoic acid (TBA)
converted from 5,5-dithiobis (2-nitrobenzoic acid) (DTNB) as de-
scribed by Akerboom and Sies [28,30,31]. GSSG was measured by re-
moval of TBA produced by the reaction of glutathione and DTNB by
addition of 2-vinylpyridine, which inhibits formation of TBA by gluta-
thione [29]. Total glutathione and GSSG levels were deﬁned as the
change in OD at 412 nm for 1 min at 37 °C.
2.9. Immunoblot analysis
A previously described method was used for preparation of kidney
protein samples for Western blot analysis [32]. Immunoblot analyses
were performed using α-smooth muscle actin (α-SMA; 1:10,000;
Sigma), catalase (1:10,000; Fitzgerald), copper-zinc superoxide
dismutase (CuZnSOD; 1:2000; Chemicon), manganese superoxide
dismutase (MnSOD; 1:2000; Calbiochem), cystathionine β-synthase
(CBS; 1:2000; Santa Cruz), cystathionine γ-lyase (CSE; 1:2000;
Santa Cruz), 4-hydroxynonenal (HNE; 1:20,000; Abcam), phospho-
NF-κB (p-NF-κB; 1:1000; Cell Signaling), TGF-β1 (1:1000; Santa
Cruz), phospho-Smad3 (p-Smad3; 1:1000; Santa Cruz), Ly6G
(1:1000; eBioscience), and GAPDH (1:5000; Santa Cruz) antibodies.
2.10. Immunostaining
Immuno-staining was performed using anti-Ly6G (1:100;
ebioscience) and anti-TGF-β (1:100; Abcam) antibodies as described
previously [33,34]. Sections were observed under an Axioplan-2
1991K.-J. Jung et al. / Biochimica et Biophysica Acta 1832 (2013) 1989–1997epiﬂuorescence (Carl Zeiss) or Nikon Fx35 microscope (Nikon, Japan).
Pictures were taken in the cortex.
2.11. Statistical analysis
Results were expressed as means ± SEM. Statistical differences
among groups were calculated using Student's t-test. A p value of
b0.05 was regarded as signiﬁcant difference.
3. Results
3.1. H2S reduces kidney ﬁbrosis after UO
UO resulted in dramatic expansion of interstitium with an in-
crease of collagen deposition, atrophy of tubules, increases of intersti-
tial cell number, and dilatation of tubules in the kidney (Fig. 1A).
Administration of NaHS (1.12, 5.6, or 28 μg/kg of BW) intraperitone-
ally into UO-induced mice daily, beginning on day one after UO, for
a period of 6 days, signiﬁcantly mitigated the deposition of collagen
and expansion of interstitium in the kidney (Fig. 1B and C). In addition,
administration of NaHS signiﬁcantly inhibited the UO-induced increase50 m
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Fig. 1. Effect of H2S on collagen deposition, expansion of interstitium and expression of α-SM
teral obstruction (UO) or sham on day 0 and kidneys were harvested 7 days after operations
28 μg/kg BW) or vehicle beginning on day one after the operation until kidney harvest, and
(A to C) Kidney sections (4 μm) were stained with Masson's trichrome for collagen depositi
interstitial area (C) were quantiﬁed using the i-Solution DT image acquisition and analysis p
Tissue sections were examined at 200× magniﬁcation. (D) Expression of α-SMA was determ
on the blot. The density of the band was quantiﬁed using ImageJ software (National Institut
presented as mean ± SEM (n = 4–5). *p b 0.05 vs. sham vehicle. #p b 0.05; ##p b 0.001.of α-smooth muscle actin (α-SMA, a marker of myoﬁbroblast, which
is a major collagen-producing cell) expression (Fig. 1D). The chosen-
dosage of NaHS was based on previous studies [16,35].
To evaluate whether effect of NaHS on ﬁbrosis is associated with
blood pressure, we measured mean arterial blood pressure (MAP)
using tail-cuff blood pressure monitoring system. UO did not result
in signiﬁcant changes of MAP compared with sham-operation at indi-
cated times (Table 1). Treatment of NaHS did not induce signiﬁcant
changes of MAP in both sham-operated and UO-induced mice
(Table 1).3.2. UO decreases H2S level and its producing enzyme expression in the
kidney
In order to determine whether UO affects the H2S production sys-
tem, we determined the expression of CBS and CSE, and H2S levels in
kidneys. UO gradually decreased CBS and CSE expression in the kid-
ney (Fig. 2A–C) and these decreases were reduced by administration
of NaHS (Fig. 2D–F). In sham-operated mice, administration of NaHS
did not induce signiﬁcant changes of expression of CBS and CSE in
the kidney (Fig. 2D–F). Consistent with the results of CBS and CSED
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on. Pictures were taken in the cortex and collagen deposition (A and B, blue color) and
rogram (IMT i-solution, Vancouver, Canada) incorporating a Nikon Fx35 (Nikon, Japan).
ined by Western blot analysis. GAPDH was used for evaluation of equal protein loading
es of Health). Band density was normalized to the density of GAPDH band. Results are
Table 1
Mean arterial blood pressure.
Surgery/
injection
n 1 day before
surgery
1 day after
surgery
3 days after
surgery
7 days after
surgery
Sham/Veh 5 95 ± 2.6 99 ± 2.2 96 ± 4.5 93 ± 6.5
Sham/NaHS 5 95 ± 2.5 98 ± 2.2 96 ± 3.7 98 ± 2.6
UO/Veh 6 96 ± 2.5 92 ± 3.1 95 ± 3.3 102 ± 5.2
UO/NaHS 5 97 ± 1.0 97 ± 3.5 97 ± 2.1 99 ± 1.9
Mice were subjected to unilateral ureteral obstruction (UO) or sham surgery (sham).
Some mice received intraperitoneal administration daily with either sodium
hydrosulﬁde hydrate (NaHS; 5.6 μg/kg BW) or 0.9% NaCl (vehicle), beginning on day
one after UO for a period of 6 days. Mean arterial pressure was measured 1 day
before, and 1, 3 and 7 days after operations and was expressed in mm Hg. Results
are expressed as means ± SEM. n, animal number.
1992 K.-J. Jung et al. / Biochimica et Biophysica Acta 1832 (2013) 1989–1997expression, H2S levels signiﬁcantly decreased 7 days after UO
(Fig. 2G) and the decrease of H2S level in the kidney signiﬁcantly mit-
igated by NaHS treatment (Fig. 2G). Administration of NaHS in
sham-operated mice did not induce signiﬁcant changes of H2S levels
in the kidneys (Fig. 2G).3.3. H2S reduces oxidative stress
Consistent with results of previous studies [21], UO signiﬁcantly in-
creased superoxide formation (Fig. 3A), hydrogen peroxide production
(Fig. 3B), and MDA production (Fig. 3C) in the kidney. In addition, UO
increased the expression of 4-hydroxynonenal (HNE) (Fig. 3D). Daily
treatment with NaHS signiﬁcantly inhibited those increases (Fig. 3). In
addition, NaHS treatment prevented the UO-induced decreases of
MnSOD, CuZnSOD, and catalase expression (Fig. 4A–D).
UO induced a signiﬁcant decrease in levels of total glutathione in
the kidneys (Fig. 5A), and daily administration of NaHS signiﬁcantly
mitigated UO-induced decreases of total glutathione levels (Fig. 5A).
In addition, NaHS treatment prevented UO-induced increases in the
ratio of GSSG to GSH (Fig. 5B). In sham-operated mice, treatment
with NaHS did not result in a change in the total glutathione level0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
D
CBS
GAPDH
CSE
UO
28
Sham
5.6 Veh 1.12 5.6NaHS Veh
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Sham UO
*
##
*
*
*
CBS
GAPDH
CSE
1Sham 73
CB
S 
ex
pr
es
si
on
(vs
. v
eh
icl
e-t
re
at
ed
 s
ha
m
)
1dSham 7d
Days after UO
3d
UO
NaHS 5.6
NaHS 28
Vehicle 
NaHS 1.12
A
CB
S 
ex
pr
es
si
on
(vs
. v
eh
icl
e-t
re
at
ed
 s
ha
m
)
E
B
*
*
Fig. 2. Changes of CBS and CSE expression and H2S level in the kidney after ureteral obstruct
(D to F) UO-mice received daily intraperitoneal administration with either NaHS (1.12, 5.6, a
vest, and sham-operated mice were administered with either NaHS (5.6 μg/kg BW) or vehicl
(A, D) Levels of CBS and CSE expression were determined by Western blot analysis. GAPDH
density of the band was quantiﬁed using ImageJ software (National Institutes of Health). Ban
were determined as described in the Materials and methods section. Results are presentedand the ratio of GSSG to total glutathione, when compared to treat-
ment with vehicle (Fig. 5).
3.4. H2S inhibits TGF-β signals, NF-kB activation, and inﬂammatory
responses
UO signiﬁcantly increased activated nuclear factor-κB (NF-κB)
levels in the kidney compared with those in sham-operated kidneys
(Fig. 6A and B). Daily treatment with NaHS, signiﬁcantly inhibited
UO-induced NF-κB activation (Fig. 6A and B). As a consequence
of NF-κB activation, we determined a level and the distribution of leu-
kocyte inﬁltrated into the kidney byWestern blot analysis and immu-
noﬂuorescence staining using Ly6G antibody. NaHS signiﬁcantly
inhibited UO-induced increase of Ly6G expression in the kidney
(Fig. 6A and C). Consistent with the level of expression, the inﬁltra-
tion of Ly6G-positive cells into the interstitium after UO was less
in the NaHS-injected mouse kidney than vehicle-injected mouse
kidney (Fig. 6D). UO signiﬁcantly increased the expression of
TGF-β1 and phosphorylated Smad3 (p-Smad3) in the kidney com-
pared to sham-operated kidneys (Fig. 7). NaHS treatment inhibited
those in UO-induced increases (Fig. 7). TGF-β1-positive signals after
UO were detected in the tubular epithelial and interstitial cells and
the expression was less in the NaHS-injected mouse kidney than
vehicle-injected mouse kidney (Fig. 7D).
4. Discussion
Findings of our present study demonstrate for the ﬁrst time that
H2S inhibits progression of kidney ﬁbrosis after UO and that the ho-
mocysteine transsulfuration pathway is involved in the progression
of UO-induced kidney ﬁbrosis. In addition, the present study also
provides important mechanistic insight with regard to H2S in the pro-
gression of kidney ﬁbrosis; H2S reduces oxidative stress by preserva-
tion of antioxidant enzymes and increase of reduced glutathione; H2S
prevents decreases of CBS and CSE expression against UO; H2S in-
hibits activation of NF-κB and TGF-β1 signals.0.0
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Fig. 3. Effect of H2S on superoxide formation, hydrogen peroxide, MDA production and 4-HNE expression in the kidney after ureteral obstruction. C57BL/6 mice were subjected to
either ureteral obstruction (UO) or sham on day 0. (A to D) UO-mice received daily intraperitoneal administration with either NaHS (1.12, 5.6, and 28 μg/kg BW) or vehicle begin-
ning on day one after the operation until kidney harvest, and sham-operated mice were administered with either NaHS (5.6 μg/kg BW) or vehicle. Kidneys were harvested 7 days
after the surgeries. (A to C) Superoxide formation, hydrogen peroxide andMDA production were determined as described inMaterials and methods. (D) Level of 4-HNE expression was
determined byWestern blot analysis. GAPDHwas used for evaluation of equal protein loading on the blot. The density of the band was quantiﬁed using ImageJ software (National Insti-
tutes of Health). Band density was normalized to the density of GAPDH band. Results are presented as mean ± SEM (n = 4). *p b 0.05 vs. sham; #p b 0.05; ##p b 0.001.
1993K.-J. Jung et al. / Biochimica et Biophysica Acta 1832 (2013) 1989–1997Homocysteine is metabolized by CBS, CSE, and 3-MST, resulting in
increases of H2S and L-cysteine, a component of glutathione. Recent
studies have demonstrated that chronic renal failure impairs homocys-
teinemetabolism via the transsulfuration pathway [11–14], resulting in
an increase in the level of homocysteine and a decrease in the level of
H2S.Wu et al. reported that ischemia/reperfusion-induced acute kidney
injury reduced CBS gene expression, resulting in accumulation of homo-
cysteine and reduction of H2S in the kidney [36]. In the present studies,
we observed that UO induced a reduction ofH2S levels in kidney togeth-
er with decreases of H2S producing enzymes, CBS and CSE, and NaHS
treatment mitigated the decreases of kidney H2S level and enzyme
expressions together with reduced ﬁbrosis. These results suggest that
H2S and its transsulfuration pathways are involved in the progression
of UO-induced ﬁbrosis.
Although the experimental model of UO generates progressive
renal ﬁbrosis independent of hypertension [39,40] which is an impor-
tant risk factor for chronic kidney diseases such as diabetic nephrop-
athy and renal ﬁbrosis, H2S plays an important role in the regulation
of vascular tension [41] and UO results in marked renal hemodynamic
changes [8,9]. Therefore we determined a role of blood pressure in
the anti-ﬁbrotic effect of H2S. In the present study, UO did not induce
signiﬁcant changes of MAP compared with sham-operated mice. In
addition, treatment of H2S into either sham or UOmice did not induce
any signiﬁcant changes of MAP. It indicates that the anti-ﬁbrotic
effect of H2S may not be associated with systemic blood pressure.Xia et al. reported that infusion of NaHS (5 to 80 nmol/min/kg BW)
and inhibitors of CSE and CBS into the rat renal artery did not induce
change of MAP and the infusion of NaHS increased renal blood ﬂow
and GFR at N10 nmol/min/kg BW NaHS concentrations [39]. UO is a
well-established experimental model in mice for the investigation of
the mechanism underlying progression of kidney ﬁbrosis [37,38].
Seven days after UO, the ligated kidney presented severe ﬁbrosis, in-
ﬂammation, oxidative stress and great loss of nephron. Those lesions
are typical characteristics in the kidney of ESRD.
ROS and oxidative stress are critical to progression of ﬁbrotic
changes [8,9,26]. H2S regulates oxidative stress by enhancing the
transport of cystine, which is reduced to cysteine in cells for synthesis
of glutathione, suppression of NADPH oxidase activity, and enhance-
ment of antioxidant enzyme activity, as well as direct scavenging of
oxygen free radicals [16,42–44]. In addition, H2S acts as an inducer
of antioxidant enzyme gene expression through regulation of Nrf2
signaling which is a transcription factor of anti-oxidant enzyme
gene expression [45]. In the present study, H2S donor treatment dur-
ing UO mitigates the increase in ROS production and oxidative stress
and the reduction in antioxidant enzyme expression. Furthermore,
NaHS treatment in UO mice resulted in signiﬁcant prevention of the
reduction of total glutathione levels in UO kidneys as well as increases
of the ratio of GSSG to total glutathione. H2S and stimulation of CBS
and CSE increase the production of glutathione which is the most
abundant antioxidant in cells [16,44] and H2S converts GSSG to GSH
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Fig. 4. Effect of H2S on expression of MnSOD, CuZnSOD, and catalase in the kidney after ureteral obstruction. C57BL/6 mice were subjected to either ureteral obstruction (UO) or
sham on day 0 and kidneys were harvested 7 days after operations. UO-mice received daily intraperitoneal administration with either NaHS (1.12, 5.6, and 28 μg/kg BW) or vehicle
beginning on day one after the operation until kidney harvest, and sham-operated mice were administered with either NaHS (5.6 μg/kg BW) or vehicle. (A to D) Expression of
MnSOD, CuZnSOD, and catalase was determined by Western blot analysis. GAPDH was used for evaluation of equal protein loading on the blot. The density of the band was quan-
tiﬁed using ImageJ software (National Institutes of Health). Band density was normalized to the density of GAPDH band. Results are presented as mean ± SEM (n = 4). *p b 0.05
vs. sham; #p b 0.0001.
1994 K.-J. Jung et al. / Biochimica et Biophysica Acta 1832 (2013) 1989–1997[46]. Xu et al. reported that treatment with NaHS prevented the re-
duction of superoxide dismutase activity induced by H2O2 [47]. In
addition, it recently reported that ACS-6, a H2S-releasing agent, in-
hibits O2− formation and NADH oxidation in endothelial cell [48].
Therefore, the anti-ﬁbrotic effect of H2S in our present study may
be associated with reduction of oxidative stress. Supporting this re-
cent studies have demonstrated that deﬁciencies in CBS and CSE en-
zymes result in decreased total glutathione levels in tissue [49] and0.0
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expression of those enzymes results in reduced susceptibility of or-
gans to I/R injury [49,50].
Inﬂammation is associated with the generation of ROS and vice
versa. UO causes inﬂammation in the kidney [8]. In the present
study NaHS treatments signiﬁcantly lowered the expression of Ly6G
following UO with mitigation of UO-induced increases of the number
of interstitial cells. Furthermore, NaHS treatment inhibited NF-κB0.0
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of equal protein loading on the blot. The density of the band was quantiﬁed using ImageJ
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Fig. 7. Effect of H2S on expression of TGF-β1 and phosphorylated Smad3 in the kidney
after UO. C57BL/6 mice were subjected to either ureteral obstruction (UO) or sham on
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5.6, and 28 μg/kg BW) or vehicle beginning on day one after the operation until kidney
harvest, and sham-operated mice were administered with either NaHS (5.6 μg/kg BW)
or vehicle. Kidneys were harvested 7 days after the surgeries. Expression of transforming
growth factor-β1 (TGF-β1, A and B) and phospho-Smad3 (A and C) was determined by
Western blot analysis. GAPDH was used for evaluation of equal protein loading on the
blot. The density of the band was quantiﬁed using ImageJ software (National Institutes
of Health). Band density was normalized to the density of GAPDH band. (D) Kidneys
were stained using anti-TGF-β antibody. Pictures were obtained from the cortex. Arrow
and arrowhead indicate interstitial and tubular TGF-β-positive cells, respectively.
Scale bar indicates 50 μm. Results are presented as mean ± SEM (n = 4). *p b 0.05 vs.
sham-vehicle; #p b 0.05; ##p b 0.01.
1995K.-J. Jung et al. / Biochimica et Biophysica Acta 1832 (2013) 1989–1997activation following UO. These results suggest that the anti-ﬁbrotic
effect of H2S is associated with declined inﬂammation. It has been re-
ported that donors of H2S including NaHS inhibited activation of
NF-κB, a transcriptional regulator of inﬂammatory genes, resulting
in reduction of inﬂammatory responses [6,48,51]. H2S signiﬁcantly re-
duced inﬂammation by inhibition of leukocyte adhesion to endothelial
cells [52], and inhibition of production of proinﬂammatory cytokinesincluding interleukin-1β (IL-1β) and tumor necrosis factor-a (TNF-α)
[53].
Kidney tubulointerstitial inﬂammatory and ﬁbrotic responses
following UO are highly associated with elevated TGF-β1 levels
[37,54]. TGF-β/Smad signals are pivotal for the induction of epithelial
to mesenchymal transition (EMT), myoﬁbroblast differentiation,
1996 K.-J. Jung et al. / Biochimica et Biophysica Acta 1832 (2013) 1989–1997apoptosis, collagen deposition, and inﬂammation; all are associated
with the progression of ﬁbrosis [8,37,55]. The blockage of TGF-β1
and Smad3 protects against chronic kidney injury and mitigates the
progression of ﬁbrosis [9,56,57]. In the present study NaHS treatment
signiﬁcantly decreased the production of TGF-β1 and activation of
Smad3 induced by UO. It suggests that the anti-ﬁbrotic effect of H2S is
associated with down-regulation of TGF-β signaling pathway, leading
to reduced inﬂammatory response and oxidative stress. Supporting
this, Yuan et al. recently reported that NaHS treatment lowered the in-
creases of TGF-β1 and collagen IV in streptozotocin-injected diabetic rat
kidney [58]. Fang et al. reported that H2S attenuated the TGF-β1-
induced EMT in human alveolar epithelial cells by the inhibition of
Smad2/3 phosphorylation [59]. In the present study, some responses
were NaHS-dose-dependent, but some were not. It suggests that there
are other targets of H2S.
Taken together, the ﬁndings of the present study suggest that H2S
plays a role as an anti-ﬁbrotic factor through, at least, in part, inhibi-
tion of oxidative stress and inﬂammatory response, as well as inhibi-
tion of TGF-β/Smad and NF-κB signals, suggesting that H2S and the
homocysteine transsulfuration pathwaymay be a useful target for de-
velopment of potent therapeutic agents against ﬁbrosis-related dis-
eases, including chronic kidney disease.Acknowledgements
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